Christoph Lawrence Bausch
CHIEF OPERATING OFFICER · SAB Biotherapeutics, Inc.
Individual
- 2025
- Feb 5, 2026
- 2
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Christoph Lawrence Bausch's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Michael Benkowitz - $135.23M in UTHR purchases and sales in the last 12 months
- Andrew T. Kaplan - $134.38M in KLRA purchases and sales in the last 12 months
- BAIN CAPITAL INVESTORS LLC - $134.38M in KLRA purchases and sales in the last 12 months
- Fairmount Funds Management LLC - $133.53M in APGE purchases and sales in the last 12 months
- Stephen M. Bloch - $125.05M in LQDA purchases and sales in the last 12 months
- Jason P. Rhodes - $124.92M in DYN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Christoph Lawrence Bausch?
Christoph Lawrence Bausch is a corporate insider, tracked as CHIEF OPERATING OFFICER of SAB Biotherapeutics, Inc. (SABS). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Christoph Lawrence Bausch last file a Form 4?
The most recent primary Form 4 on record is dated 5 February 2026, one of 2 filings going back to 2025.